Navigation Links
Labaton Sucharow Secures $473 Million Settlement In Case Against Schering-Plough Corporation
Date:2/14/2013

lleged to have made a series of material misrepresentations and omissions concerning the ENHANCE trial and the commercial viability of VYTORIN®.

"We are pleased to have secured this significant recovery for investors," said Labaton Sucharow partner Christopher McDonald, co-lead counsel for the Class.  "The settlement is even more gratifying because it underscores the value of private civil litigation to protect shareholder rights.  Multiple federal and state agencies investigated the matter, but our case is what yielded a significant financial benefit for Schering's investors."

In November 2009, Schering and Merck merged, with the surviving entity keeping the Merck name.  The settlement inures to the benefit of legacy Schering investors who purchased Schering securities between January 3, 2007 and March 28, 2008.

Labaton Sucharow represents co-lead plaintiff and class representative the Massachusetts Pension Reserves Investment Management Board.  The other co-lead plaintiffs in the Schering action are the Arkansas Teacher Retirement System, the Public Employees' Retirement System of Mississippi, and the Louisiana Municipal Police Employees' Retirement System. 

The defendants include Schering, certain of Schering's former directors and officers, the underwriters that participated in public offerings of Schering stock in August 2007, and Merck/Schering-Plough Pharmaceuticals, the joint venture formed by Schering and Merck to market VYTORIN® and another anti-cholesterol drug product, ZETIA®.  Both VYTORIN® and ZETIA® contain the drug ezetimibe.  VYTORIN® also contains the drug simvastatin, which is the active ingredient in ZOCOR®.  By comparing VYTORIN® and ZOCOR®, the ENHANCE trial sought to determine whether the additional cholesterol lowering obtained with ezetimibe would result in a biologic benefit (i.e., a reduced atheroscle
'/>"/>

SOURCE Labaton Sucharow LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. The law firms of Bernstein Litowitz Berger & Grossmann LLP and Labaton Sucharow LLP announce pendency of class action in In re Schering-Plough Corporation / ENHANCE Securities Litigation
2. Aviir Secures Second $10 Million Financing Tranche; Attracts New Investor Group
3. CyVek, Inc. Secures $5.5 Million in Series D Financing
4. Amarantus BioScience Secures an Additional $1.4 Million in Financing Commitments
5. Topokine Therapeutics Secures Financing from Schooner Capital to Advance Clinical Development of XAF5 Gel
6. Unisense FertiliTech A/S Secures 24 Million USD in New Capital Investment
7. Biomatrica Secures Financing of $5 Million
8. SurgiQuest, Inc. Secures Additional $18.5 Million Funding to Fuel Worldwide Expansion and Commercialization Efforts
9. Zafgen Secures $21 Million in Series D Financing
10. Flexion Therapeutics Secures $20 Million in Series B Financing
11. Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 Vermillion, ... on gynecologic disease, announced today it will ... after the market close on Thursday, August ... call and webcast at 4:30pm Eastern.Conference Call ... at 4:30pm Eastern/1:30pm Pacific  Domestic: ...
(Date:7/30/2015)... 2015  NanoSmart Pharmaceuticals, Inc., a private pharmaceutical ... Orphan Drug Designation from the Food and Drug ... uses NanoSmart,s proprietary drug delivery platform. The drug ... treatment of Ewing,s sarcoma, a rare type of ... Drug Designation on the basis of a plausible ...
(Date:7/30/2015)... 2015 Flexpoint Ford, a private equity firm ... announced that it has entered into a partnership with ... to form Kastle Therapeutics, LLC (Kastle).  The new company, ... on acquiring, developing and commercializing pharmaceuticals targeted toward diseases ... select therapies already approved for marketing, as well as ...
Breaking Medicine Technology:NanoSmart Receives Second FDA Orphan Drug Designation for Treatment of Pediatric Cancer 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 3
... 22, 2011 United Seating & Mobility (USM) ... transaction with Central Kentucky Mobility (CKM) to acquire and merge ... for Lexington, Louisville, as well as central, eastern and southern ... team strengthens our position within a core market for us ...
... WOONSOCKET, R.I., July 22, 2011 CVS Caremark Corporation ... conference call on Thursday, August 4, 2011, at 8:30 ... second quarter 2011 financial results. (Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO) ... will be broadcast simultaneously through the Investor Relations portion ...
Cached Medicine Technology:CVS Caremark Corporation to Hold Second Quarter 2011 Conference Call 2
(Date:7/30/2015)... ... July 30, 2015 , ... ... Biz Report, which takes a look at small, medium, and large businesses making ... business expert, conducted the business review and shared with viewers how DevExpress has ...
(Date:7/30/2015)... ... July 30, 2015 , ... 24/7 Care At Home, a high-quality ... Bernardino, recently announced that the Centers for Medicare and Medicaid (CMS) have awarded its ... care providers. 24/7 Care At Home’s agency is one of three top Orange County ...
(Date:7/30/2015)... ... , ... The need for accessibility is never greater than when we find ... well as visiting friends and family during these critical moments, hospitals around the Pennsylvania ... powered by ChargeItSpot , a Philadelphia-based startup that recently secured a $4M Series ...
(Date:7/30/2015)... ... 2015 , ... OncLive®’s extensive roster of Strategic ... Cancer Center (JCCC) mutually agreed to collaborate on projects that promote groundbreaking ... groups will help spread the news about the center’s leading-edge cancer research, robust ...
(Date:7/30/2015)... ... 2015 , ... Zejax is a New Way of Training ... , World renown body weight trainer, Paul Ziachik, announces today that he ... a person’s training capability. , The American College of Sports Medicine states that ...
Breaking Medicine News(10 mins):Health News:Software to Develop High-Performance Data-Driven Apps was Featured on NewsWatch Television 2Health News:24/7 Care At Home Earns a 5-Star Rating from the Centers for Medicare and Medicaid (CMS) 2Health News:Hospitals Add Phone Charging Stations as an Amenity for Patients and Visitors 2Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 2Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 3Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 4Health News:Zejax is a Revolutionary New Way of BodyWeight Training Without Weights 2
... April 12 (HealthDay News) -- A new study finds that ... spending, which is more than twice as high as previous ... to prevent obesity, said the researchers from Cornell University in ... medical costs are $2,741 a year higher (in 2005 dollars) ...
... Toxoplasma gondii parasite, the cause of ... birth defects in the United States. The researchers used a ... of Allergy and Infectious Diseases (NIAID), part of the National ... that children acquire from their acutely infected mothers while in ...
... , Chapel Hill, NC In a paper published today ... University of North Carolina at Chapel Hill unveils the first ... measurement of the mechanism behind drug-resistant cancer and rational prediction ... in human tissues that play a key role in cell ...
... THURSDAY, April 12 (HealthDay News) -- More unmarried women who ... a new government report shows. Twenty-seven percent of births ... threefold increase from 1985, researchers from the U.S. Centers for ... births outside of marriage, one parent isn,t present. But our ...
... order to accurately identify skulls as male or female, ... how the characteristics of male and female skulls differ ... University shows that these differences can be significant, even ... The researchers looked at the skulls of 27 ...
... People who have Huntington,s disease are much less likely to ... a new study that suggests the diseases share a common ... Huntington,s had a 53 percent lower risk of being diagnosed ... Huntington,s disease, the lower cancer risk applies to the other ...
Cached Medicine News:Health News:Test links strains of common parasite to severe illness in US newborns 2Health News:Test links strains of common parasite to severe illness in US newborns 3Health News:Kinase test may yield big gains for drug-resistant cancers 2Health News:More Unmarried Couples Having Babies: CDC 2Health News:Study finds significant skull differences between closely linked groups 2Health News:Huntington's Disease Linked to Reduced Cancer Risk in Study 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: